If you would like to ask our webinar guest speakers from WS Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund a question please submit them here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksHONY.L Regulatory News (HONY)

  • There is currently no data for HONY

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Monthly Update - June 2022

3 Aug 2022 07:00

RNS Number : 6687U
Honeycomb Investment Trust PLC
03 August 2022
 

NOT FOR PUBLICATION, DISTRIBUTION OR RELEASE, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES, ANY MEMBER STATE OF THE EUROPEAN ECONOMIC AREA (OTHER THAN THE UNITED KINGDOM), CANADA, AUSTRALIA, THE REPUBLIC OF SOUTH AFRICA OR JAPAN OR ANY OTHER JURISDICTION IN WHICH THE DISTRIBUTION OR RELEASE WOULD BE UNLAWFUL

03 August 2022

Honeycomb Investment Trust plc

Honeycomb Investment Trust plc (the "Company" or "Honeycomb") announces that the Investment Manager's monthly factsheet for 30 June 2022 is now available on its website at http://www.honeycombplc.com.

Net Asset Value per Share

The Company announces that its unaudited Net Asset Value ("NAV") per share as at 30 June 2022 on a cum-income basis was 1,019.7 pence, based on a NAV of £354.2 million, and on an ex-income basis was 1,019.3 pence, based on a NAV of £354.1 million. The NAVs have been calculated by Apex Fund Services (UK) Ltd.

Honeycomb delivered a NAV return of 0.69% for the month, which is equivalent to 8.4% per annum. NAV return was driven by strong risk adjusted yield of 9.2%. Net Investment Assets remained broadly stable in the month at £583m with cash received from the recent Oplo Mortgage Portfolio sale being re-invested.

Pollen Street Credit had another active quarter for deployment completing a number of new transactions and facility upsizes. These include a £65m senior facility to Ark, a Swedish lender focused on providing financing to European technology businesses with each loan benefiting from a 70% principal guarantee from the European Infrastructure Fund; a £65m senior facility to TIER, the leading micro-mobility business in Europe; a £50m senior facility to Splend a vehicle leasing and financing business focused on the ridesharing and delivery driver markets in the UK and Australia; a €50m facility to Earlsfort, a residential development finance lender in Ireland; and we upsized our senior facility to iwoca by £25m, financing their UK SME portfolio. Honeycomb participated in a number of these transactions.

The pipeline of new opportunities is strong with over £400m of transactions in documentation or late stage DD across a range of end subsectors including insurance run off, SME asset backed and probate finance. The broader European pipeline is standing at over £2bn and is well diversified across subsectors and asset classes.

The broader macro environment remains uncertain with a number of risks and concerns with the impact of inflation and higher interest rates the most immediate threat albeit offset somewhat by continuing high levels of employment and rising nominal wages. We are monitoring the performance of the underlying assets closely and we are still seeing very consistent and good performance. We are factoring in the impact of higher prices and interest rates when underwriting and structuring and are also seeing opportunities in sectors with low correlation to the macro. The uncertain environment is also presenting opportunities and we are taking the opportunity to increase returns on new transactions alongside continuing to ensure prudent LTVs such that our investments are able to withstand significant stresses without impairment.

At the General Meeting of the Company held on 1 June 2022, shareholders approved the Company's proposed combination with Pollen Street Capital Holdings Limited ("Pollen Street") (the "Combination"). The Company and Pollen Street are finalising the remaining conditions precedent to complete the Combination within the coming weeks. The key timing dependency for completion is the receipt of remaining change in control approvals from certain regulators with oversight of firms within the Pollen Street Group, and the funds it manages or advises. Pollen Street and the Company have filed all documentation requested by those regulators, and the Financial Conduct Authority and Prudential Regulation Authority approved the change in control on 1 August. The Company will update shareholders when the remaining approvals have been received and completion can proceed.

For further information about this announcement please contact:

Pollen Street Capital - Investment Manager

Matthew Potter / Julian Dale: +44 (0)20 3728 6750

Barclays Bank PLC - Joint Broker

Neal West / Dion Di Miceli / Chris Madderson / Stuart Muress: +44 (0) 20 7623 2323

Liberum Capital Limited - Joint Broker

Chris Clarke: +44 (0)20 3100 2000 

Cenkos Securities plc - Joint Broker

Justin Zawoda-Martin: +44 (0)20 7397 8900

Link Company Matters Limited - Corporate Secretary

hitcosec@linkgroup.co.uk

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
NAVZLLFBLVLEBBZ
Date   Source Headline
1st Nov 20213:58 pmRNSDirector Declaration
28th Oct 202110:42 amRNSNAV and Monthly Update August 2021 - Replacement
28th Oct 20217:00 amRNSNAV and Monthly Update September 2021
20th Oct 202111:57 amRNSHolding(s) in Company
1st Oct 20217:05 amRNSDirector Declaration
29th Sep 20217:00 amRNSNAV and Monthly Update September 2021
15th Sep 20217:00 amRNSHalf-year Report
8th Sep 20214:53 pmRNSNotification of Board Committee Changes
8th Sep 20217:00 amRNSDividend Declaration
7th Sep 20217:00 amRNSNAV and Monthly Update - July 2021
28th Jul 20217:00 amRNSNAV and Monthly Update - June 2021
29th Jun 20217:00 amRNSNAV and Monthly Update - May 2021
8th Jun 20215:15 pmRNSResult of AGM
28th May 20219:39 amRNSDirector/PDMR Shareholding
27th May 20217:00 amRNSNAV and Monthly Update - April 2021
14th May 202111:54 amRNSDirector/PDMR Shareholding
10th May 20214:53 pmRNSPosting of Annual Report and Notice of AGM
30th Apr 20217:02 amRNSAnnual Report and Audited Financial Statements
30th Apr 20217:01 amRNSDividend Declaration
30th Apr 20217:00 amRNSNAV and Monthly Update - March 2021
1st Apr 20217:00 amRNSNAV and Monthly Update - February 2021
4th Mar 20217:00 amRNSNAV and Monthly Update - January 2021
26th Feb 20217:00 amRNSDividend Declaration
25th Feb 20214:14 pmRNSBoard Committee Changes & SID Appointment
12th Feb 20217:00 amRNSNAV and Monthly Update - December 2020
12th Jan 20211:43 pmRNSHolding(s) in Company
12th Jan 20211:40 pmRNSHolding(s) in Company
12th Jan 202111:38 amRNSHolding(s) in Company
7th Jan 20217:00 amRNSNAV and Monthly Update - November 2020
29th Dec 202012:22 pmRNSDirectorate Change
18th Dec 202010:21 amRNSKepler Trust Intelligence: New Research
1st Dec 20207:01 amRNSMonthly Update – October 2020
1st Dec 20207:00 amRNSNet Asset Value(s)
20th Nov 20207:00 amRNSTransaction in Own Shares & Total Voting Rights
19th Nov 20207:00 amRNSDividend Declaration
19th Nov 20207:00 amRNSTransaction in Own Shares & Total Voting Rights
18th Nov 20207:00 amRNSTransaction in Own Shares & Total Voting Rights
16th Nov 20204:54 pmRNSHolding(s) in Company
13th Nov 202011:11 amRNSDirector/PDMR Shareholding
13th Nov 20207:00 amRNSTransaction in Own Shares & Total Voting Rights
12th Nov 20209:50 amRNSHolding(s) in Company
12th Nov 20207:00 amRNSTransaction in Own Shares & Total Voting Rights
11th Nov 20207:00 amRNSShare Buy-Back Programme
6th Nov 20207:00 amRNSTransaction in Own Shares & Total Voting Rights
5th Nov 20207:00 amRNSTransaction in Own Shares & Total Voting Rights
4th Nov 20207:01 amRNSMonthly Update - September 2020
4th Nov 20207:00 amRNSNet Asset Value(s)
4th Nov 20207:00 amRNSTransaction in Own Shares & Total Voting Rights
3rd Nov 20207:00 amRNSTransaction in Own Shares & Total Voting Rights
2nd Nov 20205:01 pmRNSDirector Declaration

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.